| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/26/2002 | US20020137714 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 09/26/2002 | US20020137672 Radiolabeled annexins |
| 09/26/2002 | US20020137221 Method of preserving oxygen infusions |
| 09/26/2002 | US20020137137 Genetic engineering; polypeptides |
| 09/26/2002 | US20020137023 Methods and compositions for targeting compounds to muscle |
| 09/26/2002 | US20020136819 Conserved concentrations of cocoa polyphenols by mixing carbohydrate or protein containing ingredients with a polyphenol conserving pretreatment ingredient and then with a cocoa polyphenol |
| 09/26/2002 | US20020136786 Composition and method for smoke detoxification |
| 09/26/2002 | US20020136776 Poly( alpha -hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents |
| 09/26/2002 | US20020136775 Aldosterone receptor blockers |
| 09/26/2002 | US20020136771 Stabilized ascorbic acid composition |
| 09/26/2002 | US20020136770 Method of delivering active material within hydrogel microbeads |
| 09/26/2002 | US20020136769 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 09/26/2002 | US20020136768 Quaternary ammonium compound, a hydrophilic film-forming agent, a hydrophobic waterproofing agent, a surfactant, and water for hand washing |
| 09/26/2002 | US20020136767 Controlling particle size of volatile excipients to </= 70 microns |
| 09/26/2002 | US20020136763 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 09/26/2002 | US20020136760 Carboxylated phosphatidic acid esters |
| 09/26/2002 | US20020136750 Acidified nitrite as an antimicrobial agent |
| 09/26/2002 | US20020136746 Cosmetic compositions comprising alk(en)ylsuccinic acid derivatives |
| 09/26/2002 | US20020136744 Sustained release drug dispersion delivery device |
| 09/26/2002 | US20020136735 Preparations that potentiate immunogenicity in low immunogenic antigens |
| 09/26/2002 | US20020136732 Compositions comprising carriers and transportable complexes |
| 09/26/2002 | US20020136731 Targeted therapeutic delivery of vitamin D compounds |
| 09/26/2002 | US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 09/26/2002 | US20020136719 For biomedical applications, including biological delivery to humans and animals |
| 09/26/2002 | US20020136690 Detection and treatment of infections with immunoconjugates |
| 09/26/2002 | US20020136689 Antibody which specifically binds to prostate stem cell antigen on surface of carcinoma cells and is internalized within carcinoma cells to which it binds |
| 09/26/2002 | US20020136688 Methods for treating AVM's using radioactive compositions |
| 09/26/2002 | US20020135085 Production scale method of forming microparticles |
| 09/26/2002 | DE10113366A1 Medicament for treating inflammatory or obstructive respiratory diseases, e.g. asthma or chronic obstructive pulmonary disease, containing synergistic combination of anticholinergic agent and endothelin antagonist |
| 09/26/2002 | DE10110391A1 Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff Highly flexible nicotine transdermal therapeutic system with nicotine as a drug |
| 09/26/2002 | CA2771039A1 Device and method for the photodynamic diagnosis of tumor tissue |
| 09/26/2002 | CA2469846A1 New interferon beta-like molecules |
| 09/26/2002 | CA2445486A1 Patch for transcutaneous immunization |
| 09/26/2002 | CA2441902A1 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 09/26/2002 | CA2441147A1 Methods of treating disorders of the eye and surrounding tissue with thymosin .beta.4 (t.beta.4), analogues, isoforms and other derivatives |
| 09/26/2002 | CA2441057A1 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 09/26/2002 | CA2440480A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 09/26/2002 | CA2440261A1 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
| 09/26/2002 | CA2439757A1 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells |
| 09/26/2002 | CA2439315A1 Compositions useful in gene therapy |
| 09/26/2002 | CA2438942A1 Influenza vaccine formulations for intradermal delivery |
| 09/26/2002 | CA2438308A1 Peg-conjugates of hgf-nk4 |
| 09/26/2002 | CA2435825A1 New composition |
| 09/26/2002 | CA2434030A1 Stabilized formulation of selective ligands of retinoic acid gamma-receptors |
| 09/26/2002 | CA2404581A1 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 09/25/2002 | EP1243581A1 Pyridinium compounds useful for the treatment of AGE-related diseases |
| 09/25/2002 | EP1243276A1 Elongated and multiple spacers containing activatible prodrugs |
| 09/25/2002 | EP1243275A1 Insulin-containing medicament for peroral application and method for the production thereof |
| 09/25/2002 | EP1243272A2 Crystalline amifostine compositions and methods for the preparation and use of same |
| 09/25/2002 | EP1243269A2 Opioid formulations having extended controlled release |
| 09/25/2002 | EP1243267A2 Amoxycillin and clavulanate containing pharmaceutical formulation |
| 09/25/2002 | EP1243259A1 Sustained release preparation comprising one or more antibiotics and polymers |
| 09/25/2002 | EP1243258A1 Production of a preparation comprising one or more antibiotics |
| 09/25/2002 | EP1243257A1 Sustained release preparation comprising one or more antibiotics |
| 09/25/2002 | EP1243256A1 Vaccines absorbable by the transmucosal way |
| 09/25/2002 | EP1243255A2 Method of preparation of antibiotic compositions |
| 09/25/2002 | EP1243252A1 Skin composition containing fibres and ubiquinones |
| 09/25/2002 | EP1242609A2 Novel colloid synthetic vectors for gene therapy |
| 09/25/2002 | EP1242608A2 Method of achieving persistent transgene expression |
| 09/25/2002 | EP1242576A1 Stabilizing diluent for polypeptides and antigens |
| 09/25/2002 | EP1242447A1 Compounds and use thereof to modify transport across cell membranes |
| 09/25/2002 | EP1242401A1 Cytotoxic agents comprising taxanes and their therapeutic use |
| 09/25/2002 | EP1242365A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 09/25/2002 | EP1242314A1 Production of pyrogen controlled water |
| 09/25/2002 | EP1242123A2 Absorbing fat with chitosan |
| 09/25/2002 | EP1242122A2 Delivery of proteins across polar epithelial cell layers |
| 09/25/2002 | EP1242121A2 Polypeptide compositions with improved stability |
| 09/25/2002 | EP1242106A1 Carbon dioxide enhancement of inhalation therapy |
| 09/25/2002 | EP1242103A1 Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof |
| 09/25/2002 | EP1242095A1 Antimicrobial compositions and methods of use |
| 09/25/2002 | EP1242088A1 Oral mucosal dosage forms of apomorphine |
| 09/25/2002 | EP1242087A2 Analgesic compositions containing buprenorphine |
| 09/25/2002 | EP1242073A2 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 09/25/2002 | EP1242067A2 Calcium formate for use as a phosphorus binder and a dietary supplement |
| 09/25/2002 | EP1242059A2 Novel prodrugs for antimicrobial amidines |
| 09/25/2002 | EP1242057A2 Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| 09/25/2002 | EP1242055A1 Hydrogel-driven drug dosage form |
| 09/25/2002 | EP1242054A2 Odor-masking coating for a pharmaceutical preparation |
| 09/25/2002 | EP1242047A1 Fenofibrate galenic formulations and method for obtaining same |
| 09/25/2002 | EP1242013A1 Oral transmucosal drug dosage using solid solution |
| 09/25/2002 | EP1242012A1 Improved transdermal contraceptive delivery system and process |
| 09/25/2002 | EP1242009A1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds |
| 09/25/2002 | EP1241943A1 Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same |
| 09/25/2002 | EP1146897B1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair |
| 09/25/2002 | EP1135682A4 Nanoparticles with polymer shells |
| 09/25/2002 | EP1067905B1 Fizzy formulations |
| 09/25/2002 | EP1030668A4 Penetration enhancing and irritation reducing systems |
| 09/25/2002 | EP1017413B1 Liquid interferon-beta formulations |
| 09/25/2002 | EP1003528B1 Method of enhancing bioavailability of fexofenadine and its derivatives |
| 09/25/2002 | EP0994710B1 Pharmaceutical compositions for oral administration, comprising a benzhydrylpiperazine and a cyclodextrin |
| 09/25/2002 | EP0913159B1 Drug delivery system using galactoxyloglucan |
| 09/25/2002 | EP0862416B1 Non-polymeric sustained release delivery system |
| 09/25/2002 | EP0845981B1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| 09/25/2002 | EP0753297B1 Lotion |
| 09/25/2002 | EP0753070B1 Novel nucleic acid/polymer complexes, method for preparing same and use thereof for cell transfection |
| 09/25/2002 | EP0744939B1 Bilayer preparations made from digalactosyldiacylglycerol containing galactolipid |
| 09/25/2002 | EP0587715B1 Water insoluble derivatives of polyanionic polysaccharides |
| 09/25/2002 | CN1371388A Hexapeptide with stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation differentiation and apoptosis |
| 09/25/2002 | CN1371366A Benzamide formulation with histone deacetylase inhibitor activity |
| 09/25/2002 | CN1371292A Radiopharmaceutical products and their preparation procedure |